News & Events CTI Announces Kevin M. Schwarz Promoted to Chief Operating Officer

CTI Clinical Trial and Consulting Services Announces Kevin M. Schwarz Promoted to Chief Operating Officer

April 24, 2014

CTI Clinical Trial and Consulting Services Announces Kevin M. Schwarz Promoted to Chief Operating Officer

FOR IMMEDIATE RELEASE [Cincinnati, OH ~ April 24, 2014]

CTI Clinical Trial and Consulting Services (CTI) a global, privately held, full-service contract research organization, announces Kevin M. Schwarz has been promoted to Chief Operating Officer, with direct management oversight of CTI’s global clinical trial operations.

Schwarz has been with CTI since 2003, serving as Senior Vice President of Clinical Operations. He has been vital to the growth and success of the clinical operations department at CTI as it has evolved and expanded over the past decade. In his new role, Schwarz will continue to lead further global expansion and standardization of clinical operations for CTI across the world. 

Schwarz has nearly 30 years of experience in a variety of areas in business and operations, including within the clinical research industry. Before joining CTI, he held several positions with Kendle International (now INC Research), including Director of North American Clinical Operations and Vice President of Operations. Kevin received a bachelor’s of science degree from Miami University.

“It is exciting to lead the many innovative life-saving clinical programs that CTI is managing on behalf of our pharmaceutical and biotechnology partners,” said Schwarz. “I look forward to continuing my involvement in the management of CTI clinical operations and helping to bring a number of these life-saving programs to approval, making them available to the patients who desperately need them.”

“Over the past decade, Kevin has led the expansion of CTI’s clinical operations to its current global state, and has brought a level of professionalism and standardization across many global processes,” according to Timothy J. Schroeder, CTI Chief Executive Officer. “I look forward to working directly with him in his new role as Chief Operating Officer to continue the growth curve we have established over the last 10 years.”

About CTI Clinical Trial and Consulting Services

CTI Clinical Trial and Consulting Services is an innovative, international drug and device development organization that delivers a full spectrum of clinical trial and consulting services from bench to commercialization with a focus on immunology and a passion for helping life-changing therapies succeed in chronically and critically ill patient populations. CTI’s focused therapeutic approach provides pharmaceutical, biotechnology and startup firms with clinical and disease area expertise from a unique mix of academic, medical and industry specialists; rich intellectual capital in transplantation, immunology, infectious diseases, hematology, cardiology, nephrology, hepatology, regenerative medicine and rare diseases; flexible study designs that accelerate development programs and deliver high approval ratings that are among the best in the industry; and exceptional global project management and gold standard safety and data management systems that strengthen their program’s success potential. Established in 1999 and headquartered in Cincinnati, OH; CTI has offices in North America, Europe and South America.

Original Press Release

Subscribe to our mailing list

* indicates required